Dementia News and Resources for Healthcare

DMARDs for rheumatoid arthritis linked to lower dementia risk

April 12, 2024 - Research published in Rheumatic & Musculoskeletal Disease found that patients with rheumatoid arthritis (RA) who were taking biological disease-modifying antirheumatic drugs (DMARDs) had a 24% lower risk of dementia. Previous studies have linked RA with an elevated risk of dementia, identifying chronic systemic inflammation and dysregulation of...

Biogen and Eisai Secure Traditional FDA Approval for Lequembi

July 07, 2023 by Veronica Salib

On July 6, 2023, the FDA granted Biogen Inc and Eisai Co’s Lequembi traditional FDA approval. The approval was based on a supplemental Biologics License Application (sBLA) and prior accelerated...

Initiating Dementia Treatment, Pharmacological Interventions

December 14, 2022 by Veronica Salib

The WHO notes that approximately 55 million people in the world have dementia. Considering the rate of aging and the complications that coincide with aging, Alzheimer's Disease International anticipates that the number of people with...

US Department of Defense Grants $2.97 Million to Treventis

October 28, 2022 by Veronica Salib

According to a press statement released on October 18, 2022, the Treventis Corporation, a biotechnology company, was granted $2.97 million to research and develop an anti-tau misfolding drug. The press...

Psychotropic Medications Linked to an Increased Risk of Parkinson’s

July 13, 2022 by Veronica Salib

A study published in the Annals of Clinical and Translational Neurology found that psychotropic medication use in women may be associated with an increased risk of developing Parkinson’s disease...

Revolutions in Neuroscience: Deep Brain Stimulation

July 11, 2022 by Veronica Salib

Deep brain stimulation (DBS) — a neurosurgical approach for treatment-resistant neurological disorders — has become a revolutionary addition to the field of neuroscience and a beneficial tool for neurologists, neurosurgeons,...